| Seroprevalence of SARS-CoV-2 among frontline health care personnel in a multistate hospital network—13 academic medical centers, April–June 2020 WH Self MMWR. Morbidity and mortality weekly report 69, 2020 | 242 | 2020 |
| Decline in SARS-CoV-2 antibodies after mild infection among frontline health care personnel in a multistate hospital network—12 states, April–August 2020 WH Self MMWR. Morbidity and mortality weekly report 69, 2020 | 156 | 2020 |
| Serologic testing of US blood donations to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–reactive antibodies: December 2019–January 2020 SV Basavaraju, ME Patton, K Grimm, MAU Rasheed, S Lester, L Mills, ... Clinical Infectious Diseases 72 (12), e1004-e1009, 2021 | 79 | 2021 |
| Serologic testing of US blood donations to identify SARS-CoV-2-reactive antibodies: December 2019-January 2020 SV Basavaraju, ME Patton, K Grimm, MAU Rasheed, S Lester, L Mills, ... Clinical Infectious Diseases: An Official Publication of the Infectious …, 2020 | 63 | 2020 |
| Polycaprolactone/maltodextrin nanocarrier for intracellular drug delivery: formulation, uptake mechanism, internalization kinetics, and subcellular localization M Korang-Yeboah, Y Gorantla, SA Paulos, P Sharma, J Chaudhary, ... International journal of nanomedicine, 4763-4781, 2015 | 25 | 2015 |
| Impact of maternally derived pertussis antibody titers on infant whole-cell pertussis vaccine response in a low income setting R Ibrahim, SA Ali, AM Kazi, A Rizvi, LB Guterman, RA Bednarczyk, E Kim, ... Vaccine 36 (46), 7048-7053, 2018 | 16 | 2018 |
| Inactivation of ID 4 promotes a CRPC phenotype with constitutive AR activation through FKBP 52 JB Joshi, D Patel, DJ Morton, P Sharma, J Zou, D Hewa Bostanthirige, ... Molecular oncology 11 (4), 337-357, 2017 | 16 | 2017 |
| Development and validation of a robust multiplex serological assay to quantify antibodies specific to pertussis antigens G Rajam, G Carlone, E Kim, J Choi, S Paulos, SH Park, A Jeyachandran, ... Biologicals 57, 9-20, 2019 | 15 | 2019 |
| Intra-tumoral delivery of functional ID4 protein via PCL/maltodextrin nano-particle inhibits prostate cancer growth M Korang-Yeboah, D Patel, D Morton, P Sharma, Y Gorantla, J Joshi, ... Oncotarget 7 (42), 68072, 2016 | 12 | 2016 |
| Serologic Immunity to Tetanus in the United States, National Health and Nutrition Examination Survey, 2015–2016 VD Bampoe, N Brown, L Deng, J Schiffer, LT Jia, M Epperson, Y Gorantla, ... Clinical Infectious Diseases 78 (2), 470-475, 2024 | 1 | 2024 |
| Inducible overexpression of bHLH transcriptional regulator Id4 abrogates tumorigenicity of prostate cancer xenografts D Patel, DJ Morton, M Korang-Yeboah, Y Gorantla, S Bhosle, ... Cancer Research 75 (15_Supplement), 1235-1235, 2015 | 1 | 2015 |
| Psaa Encapsulated Mucoadhesive Polycaprolactone Microparticles As Potential Intranasal Vaccine Delivery System Against Pneumococcal Infections Y Gorantla Mercer University, 2017 | | 2017 |
| PCL/Maltodextrin delivered ID4 maintains its tumor suppressor role. M Korang-Yeboah, P Sharma, AE Knowell, D Patel, Y Gorantla, ... Cancer Research 73 (8_Supplement), 4518-4518, 2013 | | 2013 |
| Muco-adhesive Polycaprolactone Microparticles as Carriers for Nasal Delivery of Vaccines Y Gorantla, MK Yeboah, R Palaniappan | | |
